Efficacy of azithromycin 1% and 1.5% ophthalmic solutions compared to tobramycin 0.3% eye drops: A systematic review and meta-analysis

被引:2
|
作者
Alemu, Birhanu Motbaynor [1 ]
Worku, Teshager [2 ]
机构
[1] Haramaya Univ, Coll Hlth & Med Sci, Sch Pharm, POB 235, Harar, Ethiopia
[2] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia
来源
SAGE OPEN MEDICINE | 2020年 / 8卷
关键词
Azithromycin; eye diseases; eye drops; tobramycin; efficacy; PURULENT BACTERIAL CONJUNCTIVITIS; CLINICAL-EFFICACY; 3-DAY TREATMENT; EYEDROPS; SAFETY; SIGNS; MULTICENTER; SYMPTOMS; TRIAL;
D O I
10.1177/2050312120958846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Azithromycin 1% and 1.5% ophthalmic preparations are used widely in clinical practice for the treatment of signs and symptoms of eye diseases. The aim of this study was to render conclusive evidence by comparing the efficacy of azithromycin 1% and 1.5% over tobramycin 0.3% ophthalmic solutions for the treatment of eye diseases in a short duration in terms of bacterial resolution, the cure rate, and resolving clinical sign and symptoms. Methods: Systematic searches were performed in the electronic database (MEDLINE, Embase, Emcare, CINAHL, Scopus, PubMed, ProQuest, and Web of Science) and other sources. Multicenter randomized controlled trial studies conducted in English were identified and screened. Analysis of individual studies was conducted using the OpenMeta-analyst and Review Manager Version 5.3 software. Results: Eleven studies were included in the systematic review and meta-analysis. In clinical cure rate, azithromycin 1% and 1.5% eye drops were more effective than tobramycin 0.3% eye drops in short duration dosing (<= 5 days) with a twice-a-day regimen (relative risk = 1.13; 95% confidence interval: 1.008, 1.28), whereas on increased duration (>5 days), azithromycin is almost similarly as effective as tobramycin (relative risk = 1.007; 95% confidence interval: 0.96, 1.05). There was no significant difference in efficacy of bacterial resolution of azithromycin (1%, 1.5%) eye drops compared to tobramycin (0.3%) eye drops (relative risk = 0.99; 95% confidence interval: 0.96, 1.018). Azithromycin eye drops are effective in improving the signs and symptoms of eye disease. Conclusion: Azithromycin 1% or 1.5% is more effective in the clinical cure rate of eye disease than tobramycin 0.3% eye drops in <= 5 days of treatment. It is also the best choice of treatment for improving the signs and symptoms of eye disease. So that we recommend clinicians to use azithromycin 1% or 1.5% eye drops.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis
    Robert, P. -Y.
    Bourcier, T.
    Meddeb-Ouertani, A.
    Khairallah, M.
    Zaghloul, K.
    Amraoui, A.
    Bhagat, Y.
    Pop, M.
    Cochereau, I.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2010, 33 (04): : 241 - 248
  • [2] Efficacy and Safety of Timolol Eye Drops in the Treatment of Acute MigraineA Systematic Review and Meta-Analysis
    Bartolome, Carla Vianca
    CEPHALALGIA, 2023, 43 (1supp) : 213 - 213
  • [3] Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis
    Fan, Weibin
    Wang, Qisheng
    Liang, Zuyu
    Wang, Jinyu
    Zhang, Lin
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [4] Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis
    Weibin Fan
    Qisheng Wang
    Zuyu Liang
    Jinyu Wang
    Lin Zhang
    BMC Infectious Diseases, 23
  • [5] Efficacy of tetracaine eye drops in strabismus surgery: a systematic review and meta-analysis of randomized controlled trials
    Almekhyal, Naser
    Alotaibi, Salman
    Alenezi, Zayed
    Almutairi, Salman
    Alharbi, Fahad
    Alrtam, Mohammad
    STRABISMUS, 2023, 31 (03) : 210 - 219
  • [6] Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis
    Wan, Kelvin H.
    Chen, Li Jia
    Young, Alvin L.
    OCULAR SURFACE, 2015, 13 (03): : 213 - 225
  • [7] Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis
    Torkildsen, Gail L.
    Cockrum, Paul
    Meier, Edward
    Hammonds, William M.
    Silverstein, Bruce
    Silverstein, Steven
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 171 - 178
  • [8] The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis
    Lau, Andrew
    Bradshaw, Catriona S.
    Lewis, Dyani
    Fairley, Christopher K.
    Chen, Marcus Y.
    Kong, Fabian Y. S.
    Hocking, Jane S.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (09) : 1389 - 1399
  • [9] The efficacy and safety of azithromycin in treatment for childhood asthma: A systematic review and meta-analysis
    Pan, Xiangcheng
    Liu, Yan
    Luo, Jiefeng
    Li, Siyu
    Diao, Sha
    Li, Hailong
    Huang, Liang
    Jia, Zhijun
    Chen, Lina
    Cheng, Guo
    Liu, Hanmin
    Zhang, Lingli
    PEDIATRIC PULMONOLOGY, 2022, 57 (03) : 631 - 639
  • [10] Efficacy of Adjuvants in Ophthalmic Regional Anesthesia: A Systematic Review and Network Meta-analysis
    Bodenbender, Jan-Philipp
    Eberhart, Leopold
    Paul, Christoph
    Wiesmann, Thomas
    Schubert, Florian
    Schubert, Ann-Kristin
    Dinges, Hanns-Christian
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 252 : 26 - 44